. 2016 Feb 26;11(2):e0149960. doi: 10.1371/journal.pone.0149960

Table 5. Clinical outcomes according to MRSA in comparison with MSSA.

Disease characteristics	MRSA (n = 14)	MSSA (n = 61)	P value
Antibiotics modification^a, n (%)	11(78.57)	41(67.21)	0.53
Length of stay^b, days, mean ±SD [median]	37.93 ± 47.20 [19]	18.89 ± 13.57 [15]	0.12
Mortality rate^a, n (%)	0 (0)	0 (0)	1
Cost^b, US$, mean±SD [median]	5215.21 ± 8667.48 [1943.63]	2612.64 ± 2965.28 [2145.61]	0.39
Age^b, years, mean ±SD [median]	62.50 ± 20.35 [59]	51.92 ± 17.63 [56]	0.03

^a Variables were tested using Fisher’s Exact Test while

^b variables were tested using one tailed,Wilcoxon rank sum test.